The obstetric comorbidity scoring system was developed by NIH-funded researchers for classifying severe maternal morbidity.
The system uses patient discharge data to analyze and compare rates of maternal morbidity between different U.S. hospitals and different groups of patients. The study, published in the journal Obstetrics & Gynecology, was led by Stephanie A. Leonard, PhD, of the Stanford University School of Medicine.1
Researchers studying maternal morbidity lack reliable ways to do so. The obstetric comorbidity scoring system, according to the study authors, offers an advantage over current approaches. As opposed to electronic medical records, the new scoring system relies on patient discharge records that are more readily available.2
Developed by researchers from the California Maternal Quality Care Collaborative (CMQCC), Stanford University and the University of California, Berkeley, the scoring system aids in predicting severe maternal morbidity (SMM) and non-transfusion SMM; non-transfusion SMM includes SMM cases in which blood transfusion was not the sole indicator of a severe complication.3
__
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More